Oral Presentation ESA-SRB-APEG-NZSE 2022

Modulation of mineralocorticoid receptor (MR) signalling with AZD9977 for the treatment of diabetic cardiac myopathies (#123)

Monica Kanki 1 2 , Elliott Vivekanatham 1 3 , Gregory Tesch 3 , Timothy Cole 4 , Peter Fuller 5 , Daniel Donner 6 , Helen Kiriazis 6 , Krister Bamberg 7 , Morag Young 1 8
  1. Cardiovascular Endocrinology Laboratory, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
  2. Department of Medicine (Alfred Health), Monash University, Clayton, Victoria, Australia
  3. Department of Physiology, Monash University, Clayton, Victoria, Australia
  4. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
  5. Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia
  6. Experimental cardiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
  7. Early Clinical Development, Research and Early Development, BioPharmaceuticals R&D AstraZeneca, Gothenburg, Sweden
  8. Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia
Publish consent withheld